Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.
暂无分享,去创建一个
Hai Hu | Rick Jordan | Stella B Somiari | Brenda Deyarmin | Jing He | Richard I Somiari | S. Somiari | B. Deyarmin | Hai Hu | C. Shriver | R. Jordan | J. Hooke | R. Somiari | Jing He | Kishan Parikh | S. Lubert | Lisa Malicki | C. Heckman | Craig D Shriver | Kishan Parikh | Jeffrey Hooke | Susan Lubert | Lisa Malicki | Caroline Heckman | Jing He
[1] G. Hortobagyi,et al. HER2/neu in the management of invasive breast cancer. , 2002, Journal of the American College of Surgeons.
[2] T. Kawarabayashi,et al. Establishment of a new human malignant fibrous histiocytoma cell line, FU-MFH-1: cytogenetic characterization by comparative genomic hybridization and fluorescence in situ hybridization. , 2003, Cancer genetics and cytogenetics.
[3] A. Lewiński,et al. Expression of genes for certain enzymes of pyrimidine and purine salvage pathway in peripheral blood leukocytes collected from patients with Graves' or Hashimoto's disease , 2003, Journal of cellular biochemistry.
[4] J. Reis-Filho,et al. c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant? , 2003, Breast Cancer Research.
[5] T. Shuin,et al. Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization. , 2002, Cancer genetics and cytogenetics.
[6] R. Bohle,et al. HER-2/neu gene copy number quantified by real-time PCR: comparison of gene amplification, heterozygosity, and immunohistochemical status in breast cancer tissue. , 2003, Clinical chemistry.
[7] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] J Khan,et al. Detection of gene amplification by genomic hybridization to cDNA microarrays. , 2000, Cancer research.
[9] H. Moch,et al. Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. , 2001, Journal of the National Cancer Institute.
[10] J. Siegfried,et al. Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplified DNA in a human lung carcinoma cell line , 1997, Genes, chromosomes & cancer.
[11] X. Guan,et al. Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients. , 2003, Cancer genetics and cytogenetics.
[12] P. Moore,et al. Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients , 2003, International journal of cancer.
[13] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[14] Ash A. Alizadeh,et al. Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays , 1999, Nature Genetics.
[15] M. Urioste,et al. Array comparative genomic hybridization analysis of myelodysplastic syndromes with complex karyotypes. A technical evaluation. , 2003, Cancer genetics and cytogenetics.
[16] D. Slamon,et al. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] H. Döhner,et al. Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances , 1997, Genes, chromosomes & cancer.
[18] M. Dowsett,et al. Assessment of HER2 status in breast cancer: why, when and how? , 2000, European journal of cancer.
[19] C. Ihm,et al. Detection of genetic alterations in bladder tumors by comparative genomic hybridization and cytogenetic analysis. , 1999, Cancer genetics and cytogenetics.
[20] S. Somiari,et al. Functional relationship and gene ontology classification of breast cancer biomarkers. , 2003, The International journal of biological markers.
[21] T. Fornander,et al. The Clinical Significance of Thymidine Kinase 1 Measurement in Serum of Breast Cancer Patients Using Anti-TK1 Antibody , 2000, The International journal of biological markers.
[22] L. Norton,et al. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. , 1998, Cancer research.
[23] Ash A. Alizadeh,et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays , 1999, Nature Genetics.
[24] J Piper,et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors , 1994, Genes, chromosomes & cancer.
[25] D. Slamon,et al. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J. Calvo,et al. ErbB2 and EGFR are downmodulated during the differentiation of 3T3‐L1 preadipocytes , 2003, Journal of cellular biochemistry.
[27] M. Bui,et al. Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study. , 2000, Annals of clinical and laboratory science.
[28] C. Fuster,et al. Analysis of kidney tumors by comparative genomic hybridization and conventional cytogenetics. , 2002, Cancer genetics and cytogenetics.
[29] S. Galiègue,et al. Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer. , 2003, The International journal of biological markers.
[30] H. Linardou,et al. New Molecular Targets and Therapeutic Strategies against Cancer , 1993, The International journal of biological markers.
[31] Y. Yarden,et al. Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.
[32] W. Kuo,et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.
[33] G. Houge,et al. Usefulness of high-resolution comparative genomic hybridization (CGH) for detecting and characterizing constitutional chromosome abnormalities. , 2002, American journal of medical genetics.
[34] J. Cigudosa,et al. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] Y. Tagawa,et al. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. , 2002, Lung cancer.
[36] K. Reddy,et al. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. , 2003, Molecular cancer research : MCR.